http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014045718-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_433d55f0316a5ea324961e14e297fce4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e6c10407c55c1e4f1b80a11fd73256ed http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79f8ed34ef4293fd4d1ea7b6417fe401 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3a120baf68475ef90642bae456f6277f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9c9c36f89657621507c4fde45a4cb025 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-085 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2013-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d08d5d60a49d33ec7db71a29e0bff68e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ca34fd7d5b0187a2ae86ec1d0680572 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48705bc74a0699e9c850f06783062a5f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a42d9bff52e367078009be1e2ec8418 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29b3482e6d87be8481f57b268044b360 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3377b006552fb1afd3b54ef978b010da http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_872e9d69cbe8e29bc833e2bb5b297893 |
| publicationDate | 2014-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2014045718-A1 |
| titleOfInvention | Biomarkers for inflammation of the liver |
| abstract | The invention relates to a method for the diagnostic investigation of biological samples from a person for inflammation of the liver, in particular hepatic fibrosis and/or cirrhosis of the liver, where the sample is investigated for one or more proteins as markers of inflammation of the liver, in particular hepatic fibrosis and/or cirrhosis of the liver, where a concentration of the proteins which is elevated or decreased by comparison with the healthy state indicates the presence of an inflammation of the liver, in particular a hepatic fibrosis and/or cirrhosis of the liver.; The proteins are selected from the group of ER6Q, vimentin, actin alpha 1 skeletal muscle protein, hMFAP 4, tropomyosin, PTGES 2, amyloid P component, transgelin, calponin 1, homo sapiens p20 protein, 17 kDa myosin light chain, H chain H Igg B12, prolyl 4-hydroxylase, beta subunit methylenetetrahydrofolate dehydrogenase 1, PRO2619, aldehyde dehydrogenase 1, fibrinogen alpha chain preproprotein, fructose-bisphosphate aldolase B, argininosuccinate synthetase, Eefla2, AT P 5 Al, alpha-2 actin, regucalcin, serum albumin, mitochondrial malate dehydrogenase, mitochondrial acetoacetyl-CoA thiolase or in each case a partial sequence thereof. |
| priorityDate | 2006-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1971.